CPX-351

• Description :

  CPX-351 (Vyxeos) is a liposomal encapsulant of cytarabine and Zoerythromycin with potential antitumor activity and can be used in the study of acute myeloid leukemia.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  770.74

• Molecular Formula :

  C36H42N4O15

• Notes :

  Research use only, not for human use.

• Receptor :

  Others

• CAS Number :

  1256639-86-7